n-Octyl Bromide (n-OB), also known as 1-Bromooctane (CAS No. 111-83-1), is a specialized, long-chain halogenated hydrocarbon intermediate. It functions as a precise octylating agent in complex organic synthesis. Its defining feature is the introduction of the n-octyl group into various target molecules. This specific C8 chain length is crucial for conferring desired characteristics such as enhanced lipophilicity, surface activity, or specific molecular volume necessary for the biological activity of specialized pharmaceutical and agrochemical compounds.
This product will be delivered within 1-3 business days.
The market for n-Octyl Bromide is characterized by:
- High-Value Niche Intermediate: n-OB is a low-volume, high-cost specialty chemical, with demand almost entirely project-based and driven by the synthesis of complex molecules where the C8 chain length is essential and non-substitutable.
- Pharmaceutical Sensitivity: Its market volume is heavily influenced by the manufacturing cycles of a few key drugs, such as Octenidine Dihydrochloride and Fingolimod, requiring ultra-high purity grades.
- Raw Material Specificity: Production relies on the bromination of n-Octyl Alcohol, linking its cost structure to the specialized C8 fatty alcohol market.
- Safety and Quality Focus: Due to its application in sensitive end-markets and the hazardous nature of its synthesis (involving bromine sources), safety, quality control, and regulatory compliance are paramount, acting as significant barriers to entry.
Application Analysis
n-Octyl Bromide's primary commercial value is realized in pharmaceutical and agrochemical synthesis where a specific, non-polar C8 chain is required.- Pharmaceuticals:
- Features & Trends: n-OB is a critical reagent for introducing the octyl group into pharmaceutical APIs.
- Octenidine Dihydrochloride: n-OB is a precursor for this potent antimicrobial agent, widely used in disinfectants, wound care, and mouthwashes. The octyl chain contributes to the molecule's surfactant properties and efficacy.
- Fingolimod: An immunomodulating drug used for treating multiple sclerosis. n-OB is used in its synthesis to introduce a key structural component, vital for its biological function.
- Key Trend: Demand is stable for established drugs but can surge dramatically during the launch and volume ramp-up of new drugs requiring octylation. This sector demands the highest purity (low moisture, high assay) n-OB.
- Agrochemicals:
- Features & Trends: Used in the synthesis of specialized agrochemical actives (herbicides, insecticides). The C8 chain often enhances the lipophilicity of the molecule, improving its uptake by plants or pests and increasing its overall biological efficacy.
- Key Trend: Consistent, lower-volume demand driven by the development of novel crop protection agents that rely on precise alkyl chain lengths for optimal performance.
- Others (Quaternary Ammonium Salts and Specialty Chemicals):
- Features & Trends: n-OB is used to synthesize specialty octyl-containing Quaternary Ammonium Salts and other long-chain derivatives used as surfactants, emulsifiers, or phase-transfer catalysts.
- Key Trend: Niche industrial applications where the C8 chain is optimized for specific surface or catalytic activity.
Regional Market Trends
Production is dominated by specialized fine chemical manufacturers, primarily in Asia, while consumption is tied to global pharmaceutical manufacturing centers.- Asia-Pacific (APAC): APAC is the dominant production region and a significant consumer, projected to achieve the strongest growth rate, estimated at a CAGR in the range of 3.5%-5.5% through 2030.
- India: Indian fine chemical manufacturers, including Delta Finochem Pvt Ltd. (240 tonnes capacity), Tulip Chemical Pvt. Ltd., Mody Chemi Pharma Pvt Ltd, Neogen Chemical Limited, Krishna Solvechem Limited, and Dwarkesh Chemicals (18 tonnes capacity), are major global suppliers. Their expertise in halogenation chemistry and cost-competitive production models serve the global API export market.
- China: Chinese producers like Anhui Weixiang New Material Co. Ltd. and Shandong Tongli New Material Co. Ltd. provide a competitive supply of n-OB, catering to both the rapidly expanding domestic pharmaceutical sector and international markets.
- Europe: Europe is a mature, high-value consumption market, projected to grow at a moderate CAGR in the range of 2%-4% through 2030. It is home to global chemical players, including ICL, who maintain capacity or supply from global facilities to meet the stringent quality demands of European pharmaceutical manufacturers.
- North America: North America is a stable consumer market, projected to grow at a moderate CAGR in the range of 2%-4% through 2030, driven by its domestic API and specialty chemical manufacturing.
- Latin America and Middle East & Africa (MEA): These regions represent smaller markets, projected to grow at a moderate CAGR in the range of 1.5%-3.5% through 2030, with demand linked to regional chemical and pharmaceutical expansion.
Company Profiles
The market is supported by global halogen specialists and specialized Indian fine chemical manufacturers with expertise in C8 chain derivatives.- ICL: A major global chemical firm with deep integration in the bromine value chain. ICL supplies high-quality halogen derivatives, including n-OB, ensuring compliance and reliability for high-specification customers worldwide.
- Delta Finochem Pvt Ltd. (240 tonnes capacity): A leading Indian fine chemical manufacturer. Its significant capacity positions it as a major merchant supplier of n-OB, targeting the global pharmaceutical and agrochemical synthesis markets.
- Tulip Chemical Pvt. Ltd., Mody Chemi Pharma Pvt Ltd, Neogen Chemical Limited, and Krishna Solvechem Limited: Specialized Indian fine chemical and specialty manufacturers. Neogen Chemical Limited is known for its focus on bromine chemistry, ensuring a dedicated, high-quality supply of n-OB.
- Anhui Weixiang New Material Co. Ltd. and Shandong Tongli New Material Co. Ltd.: Chinese producers who add volume and competitive pricing to the global supply, supporting the extensive fine chemical and pharmaceutical synthesis activity in China.
- Dwarkesh Chemicals (18 tonnes capacity): A smaller, highly specialized Indian producer, likely focusing on specific, low-volume, high-purity customer orders or customized synthesis requirements.
Value Chain Analysis
The n-Octyl Bromide value chain is characterized by the need for stable, specialized C8 feedstock sourcing and expertise in managing a hazardous bromination process.- Upstream: Feedstock Sourcing:
- Activity: Sourcing of n-Octyl Alcohol (1-Octanol), a higher-end specialized fatty alcohol, and a source of Bromine (such as Hydrobromic Acid or Elemental Bromine).
- Value-Add: Secure and cost-effective sourcing of 1-Octanol is critical for cost stability. Producers with integration into fatty alcohol production or strong supplier relationships have a competitive edge.
- Midstream: Bromination and Purification (Core Value-Add):
- Activity: The chemical reaction between 1-Octanol and the bromination source, followed by intensive distillation and purification to remove moisture, unreacted materials, and HBr traces.
- Value-Add: Proprietary reaction protocols and specialized equipment are necessary to handle the long-chain alcohol and achieve the ultra-high purity demanded by pharmaceutical synthesis. Rigorous safety and environmental controls for managing the corrosive and volatile nature of the process are high-cost components that drive value.
- Downstream: Fine Chemical Synthesis:
- Activity: Selling high-purity n-OB as an octylating agent to API manufacturers (e.g., for Octenidine or Fingolimod synthesis), agrochemical houses, and specialty chemical formulators.
- Value-Add: cGMP compliance, reliable documentation, and technical support in optimizing the subsequent alkylation step in the customer's synthesis pathway are essential for securing premium pricing and long-term contracts in this high-specification market.
Opportunities and Challenges
n-Octyl Bromide benefits from its unique role in essential drug synthesis but is highly vulnerable to raw material volatility and product concentration risk.Opportunities
- Essential Drug Precursor: The non-substitutable role of n-OB in the synthesis of drugs like Octenidine and Fingolimod ensures a guaranteed baseline demand, independent of general economic cycles.
- Growth in Antimicrobial and Specialty Surfactants: The increasing global focus on hygiene (driving Octenidine usage) and the demand for specialized, effective surfactants provide stable, high-value niche growth.
- New Drug Development: R&D pipelines focusing on hydrophobic drug candidates (especially in oncology and dermatology) are likely to continue requiring the introduction of specific alkyl chains like C8.
- Expertise Monetization: The complexity of the chemistry and the high purity requirements allow specialized producers (especially in India and Europe) to command premium prices and maintain healthy margins.
Challenges
- Extreme Market Concentration: The market volume is small and highly reliant on the production of a limited number of APIs. Any shift in treatment protocol or patent expiration for a major drug could cause severe and sudden demand volatility.
- Raw Material Cost Volatility: Reliance on n-Octyl Alcohol, a higher-end specialty fatty alcohol, exposes producers to cost risks beyond simple commodity fluctuations.
- Regulatory and Environmental Costs: Compliance with stringent global safety and environmental regulations for halogenated organics and API intermediates is a heavy, unavoidable fixed cost, especially concerning waste disposal and VOC management.
- Competition from Other Bromides: While C8 is unique, n-OB faces competition from n-Hexyl Bromide or n-Decyl Bromide in applications where the required chain length is slightly flexible and cost is a primary concern.
- Logistical Complexity: The low-volume, high-value nature of the product, coupled with the need for specialized handling (due to its reactive nature), adds complexity and cost to storage and global shipping.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
Chapter 4 Market Landscape
Chapter 5 Market Trend Analysis
Chapter 6 Industry Chain Analysis
Chapter 7 Latest Market Dynamics
Chapter 8 Trading Analysis
Chapter 9 Historical and Forecast n-Octyl Bromide Market in North America (2020-2030)
Chapter 10 Historical and Forecast n-Octyl Bromide Market in South America (2020-2030)
Chapter 11 Historical and Forecast n-Octyl Bromide Market in Asia & Pacific (2020-2030)
Chapter 12 Historical and Forecast n-Octyl Bromide Market in Europe (2020-2030)
Chapter 13 Historical and Forecast n-Octyl Bromide Market in MEA (2020-2030)
Chapter 14 Summary for Global n-Octyl Bromide Market (2020-2025)
Chapter 15 Global n-Octyl Bromide Market Forecast (2025-2030)
Chapter 16 Analysis of Global Key Vendors
List of Tables and Figures
Companies Mentioned
- ICL
- Delta Finochem Pvt Ltd.
- Tulip Chemical Pvt. Ltd.
- Mody Chemi Pharma Pvt Ltd
- Neogen Chemical Limited
- Krishna Solvechem Limited
- Anhui Weixiang New Material Co. Ltd.
- Shandong Tongli New Material Co. Ltd.
